Related Experiment Video
Updated: Jul 30, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
The complement system in ischemic heart disease
M Yasuda1, K Takeuchi, M Hiruma
1First Department of Internal Medicine, Osaka City University Medical School, Japan.
Insights
Complement system activation occurs in acute myocardial infarction (AMI) and is linked to heart damage. Mild activation is seen in unstable angina, but not stable angina, without cardiac dysfunction.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biochemistry
Background:
- Tissue injury mechanisms post-acute myocardial infarction (AMI) remain unclear.
- Experimental models suggest complement system involvement in AMI-related microvascular and macrovascular injury.
- The role of complement activation in angina pectoris is not well-defined.
Purpose of the Study:
- To investigate the role of the complement system as a mediator of myocardial inflammation.
- To quantify complement activation products in patients with AMI, unstable angina, stable angina, and healthy volunteers.
- To assess the association between complement activation and myocardial damage.
Main Methods:
- Quantification of complement activation products (C3d, C4d, Bb, SC5b-9) in plasma samples.
- Study included 31 AMI patients, 17 unstable angina patients, 19 stable angina patients, and 20 normal volunteers.
- Correlations between SC5b-9 levels and peak creatine phosphokinase, ejection fraction, and heart failure status were analyzed.
Main Results:
- Plasma C3d levels were elevated in AMI and unstable angina patients (p<0.01).
- Plasma levels of C4d, Bb, and SC5b-9 were increased exclusively in AMI patients (p<0.01).
- Plasma SC5b-9 levels correlated with creatine phosphokinase (r=0.71) and inversely with ejection fraction (r=-0.71), and were higher in AMI patients with heart failure.
Conclusions:
- Complement system activation is evident following AMI and associated with myocardial damage.
- Mild complement system activation occurs in unstable angina pectoris without cardiac functional impairment.
- The complement system is not activated in stable angina pectoris.
Abstract:
The mechanisms by which tissue injury after acute myocardial infarction (AMI) occurs has not been fully elucidated. Recent evidence in experimental models has suggested involvement of the complement system in microvascular and macrovascular injury subsequent to AMI. With respect to angina pectoris, whether or not the complement system is activated is not clear. The present study assessed the role of complement as a mediator of myocardial inflammation by quantifying products of complement activation, including C3d, C4d, Bb, and SC5b-9 complexes, in 31 patients with AMI, 17 patients with unstable angina pectoris, 19 patients with stable angina pectoris, and 20 normal volunteers. The plasma C3d levels increased in patients with AMI and in those with unstable angina pectoris (p less than 0.01). The plasma levels of C4d, Bb, and SC5b-9 increased only in patients with AMI (p less than 0.01). The plasma SC5b-9 level was related to peak creatine phosphokinase (r = 0.71) and inversely related to the ejection fraction (r = -0.71). The plasma SC5b-9 level of patients with congestive heart failure was higher than that of patients without congestive heart failure in AMI. These results show that activation of complement system occurs after AMI and show an association of myocardial damage with complement activation. With respect to angina pectoris, the complement system is mildly activated in patients with unstable angina pectoris; however, the cardiac function of patients with unstable angina pectoris is not damaged. The complement system of patients with stable angina pectoris is not activated.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Complement System
Myocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Stroke ll: Pathophysiology

